Zac Efron trying stem cell therapy
Zac Efron reveals he went through stem cell therapy after being ‘messed up’ by a role
Zac Efron has revealed that he is undergoing stem cell therapy to treat a back injury he sustained while filming The Iron Claw . The 36-year-old star opened up about the treatment on Instagram, sharing how he sought help from stem cell specialists after months of physical therapy failed to fully heal his injury.
Zac Efron Reveals He Received Stem Cell Therapy Following Injuries For ‘The Iron Claw’
On Tuesday, Zac Efron opened up about his journey with stem cell therapy following his training for A-24’s The Iron Claw film. Efron, 36, portrayed pro wrestler Kevin Von Erich in the 2023 movie.
Zac Efron trying stem cell therapy after suffering back injury
Zac Efron is using stem cell therapy after "messing up" his back while making a movie. The Greatest Showman actor took to Instagram on Monday to share a photo of himself with Dr. Adeel Khan at Eterna Health.
Zac Efron undergoes stem cell therapy for back injury
Zac Efron has been having stem cell therapy to treat his injured back. The 36-year-old actor's demanding 2023 wrestling movie 'The Iron Claw' - in which he portrayed pro wrestling legend Kevin Von Erich - took its "toll" on his body leaving him struggling with any kind of strenuous physical activity,
Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center
Technology Networks spoke with Nicola Alderson, COO at Anthony Nolan, to discuss some of the current stem cell supply challenges and learn more about how donor registries can help overcome stem cell supply chain issues.
Zac Efron credits stem cell therapy for recovery from 'Iron Claw' injury
Zac Efron turned to stem cell therapy to recover from injuries he sustained while playing wrestling legend Kevin Von Erich in The Iron Claw.The 36-year-old actor shared that the physically
OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M.
Flint woman with leukemia may be 1st to get stem cell transplant from deceased donor
A Flint woman may be the first in the world with leukemia to undergo a transplant using stem cells from the bone marrow of a ...
Armed robbery in Revesby23h
HiTIP-seq Maps Glioma Stem Cell Reprogramming to Therapy
Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical ...
Nature8d
Doctors cured her sickle-cell disease. So why is she still in pain?
Gene and cell therapies bring fresh hope to people with genetic disorders, but recovery can be complex and long-term support ...
Targeted Oncology1d
Lunning Evaluates CAR T-Cell Therapy for ASCT-Eligible and Ineligible DLBCL
During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...
Crain's Chicago Business8d
Stem cell tech startup with UIC roots raises $15 million
Syntax Bio has invented a modified CRISPR system that it says can transform cells more efficiently than current methods.
Teen boy first in Michigan to get gene therapy treatment for blood disorder
Children's Hospital of Michigan is treating the first person in Michigan with a newly approved gene-editing therapy for beta thalassemia.
The new frontier of luxury travel is a $44,000 course of stem cells and a longevity club stocked with IV stations
It's just a snippet of what happens on a Storylines’ wellness cruise, all in the name of longevity tourism—a rapidly growing ...